Synthesis and biological evaluation of novel anthranilamide derivatives as anticancer agents

Jianzhen Liu1, Wen Liang, Yuanyou Wang

  • 1Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, Ji'nan, Shandong, China.

Insights

New anthranilamide derivatives show potent anticancer effects. Compound 7c effectively inhibits colon and breast cancer cell growth by inducing apoptosis and cell cycle arrest, offering a promising lead for novel cancer therapies.

Area of Science:

  • Medicinal Chemistry
  • Cancer Biology
  • Pharmacology

Background:

  • Cancer remains a leading cause of mortality worldwide, necessitating the development of novel therapeutic agents.
  • Anthranilamide derivatives represent a class of compounds with potential anticancer properties.

Purpose of the Study:

  • To synthesize and evaluate novel anthranilamide derivatives for antiproliferative activity against human cancer cell lines.
  • To identify specific compounds with significant anticancer potential and elucidate their mechanism of action.

Main Methods:

  • Synthesis of a series of anthranilamide derivatives.
  • In vitro antiproliferative assays using human colon carcinoma (HCT 116) and breast adenocarcinoma (MDA-MB-231) cell lines.
  • Flow cytometric analysis to determine the mechanism of cell death and cell cycle effects.

Main Results:

  • Compounds 7a-7d, 11a, and 11b demonstrated promising antiproliferative activity.
  • Compound 7c exhibited the most potent activity against both HCT 116 and MDA-MB-231 cell lines.
  • Compound 7c induced apoptosis in a dose-dependent manner and caused G1/S phase arrest in HCT 116 cells.

Conclusions:

  • Anthranilamide derivatives, particularly compound 7c, show significant potential as anticancer agents.
  • Compound 7c's ability to induce apoptosis and cell cycle arrest warrants further investigation for cancer therapy development.
  • Compound 7c represents a promising lead candidate for the development of novel anticancer drugs.

Related Concept Videos

Physical Properties of Amines01:26

Physical Properties of Amines

Amines with low molecular weight are usually gaseous at room temperature, while those with high molecular weight are liquid or solids in nature. Usually, low molecular weight amines have a rotten fish-like smell. Diamines typically have a pungent smell. For instance, cadaverine and putrescine, depicted in Figure 1, are two molecules responsible for decaying tissue.
Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
2° Amines to N-Nitrosamines: Reaction with NaNO201:20

2° Amines to N-Nitrosamines: Reaction with NaNO2

Secondary amines react with nitrous acid to form N-nitrosamines, as depicted in Figure 1. Nitrous acid, a weak and unstable acid, is formed in situ from an aqueous solution of sodium nitrite and strong acids, such as hydrochloric acid or sulfuric acid, in cold conditions. In the presence of an acid, the nitrous acid gets protonated. The subsequent loss of water results in the formation of the electrophile known as nitrosonium ion.